Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations
Author:
Ibiayi Dagogo-Jack,Owen Mitchell,Elizabeth Codd,Annie Li,Dawn Mitchell,Samantha E. Flynn,Nanna Sivamanoharan,Patrick Reeves,Mark C. Poznansky,Ivan Valiev,Artem Kosmin,Beow Y. Yeap,Grace Hambelton,Anthony John Iafrate,Jochen K. Lennerz,Yin P. Hung et al.
Publication:
Journal of Thoracic Oncology
© 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.